Welcome to the December issue of Pathway, a monthly magazine designed for anyone interested in their health and wellbeing and in the integral role that pathology plays in the diagnosis, treatment and management of diseases.
This month’s issue of Pathway looks at the following:
Experts around the world are monitoring Omicron closely to see how it will affect the pandemic. Prof Dominic Dwyer explains what we know about this new variant so far.
One year on from IPD 2020, Prof Rawlinson reflects on the statements he made, what has changed, what hasn’t changed, and how some things can be moved forward with COVID-19.
What is pharmacogenetics and should we be using it?
A report in 2008 estimated that the widespread implementation of Pharmacogenetics testing in Australia could yield savings in excess of $1 billion annually.
The RCPA’s Scientific Program Committees have produced another attractive spread of topics that will offer valuable new learning experiences at Pathology Update 2022.
